XML 12 R2.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statement of Earnings (Unaudited) - USD ($)
shares in Thousands, $ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]        
Net sales $ 10,410 $ 10,928 $ 33,562 $ 31,607
Cost of products sold, excluding amortization of intangible assets 4,629 4,423 14,549 13,771
Amortization of intangible assets 498 520 1,517 1,533
Research and development 782 672 2,163 1,980
Selling, general and administrative 2,731 2,767 8,275 8,276
Total operating cost and expenses 8,640 8,382 26,504 25,560
Operating earnings 1,770 2,546 7,058 6,047
Interest expense 141 133 404 402
Interest (income) (55) (10) (95) (32)
Net foreign exchange (gain) loss 19 4 16 7
Other (income) expense, net (93) (74) (253) (214)
Earnings before taxes 1,758 2,493 6,986 5,884
Taxes on earnings 323 393 1,086 802
Net Earnings $ 1,435 $ 2,100 $ 5,900 $ 5,082
Basic Earnings Per Common Share (in dollars per share) $ 0.82 $ 1.18 $ 3.35 $ 2.85
Diluted Earnings Per Common Share (in dollars per share) $ 0.81 $ 1.17 $ 3.32 $ 2.83
Average Number of Common Shares Outstanding Used for Basic Earnings Per Common Share (in shares) 1,752,968 1,774,516 1,756,209 1,776,870
Dilutive Common Stock Options (in shares) 10,685 14,483 11,638 14,407
Average Number of Common Shares Outstanding Plus Dilutive Common Stock Options (in shares) 1,763,653 1,788,999 1,767,847 1,791,277
Outstanding Common Stock Options Having No Dilutive Effect (in shares) 5,445 2,740 2,655 2,694